TABLE 2

Model parameter estimates in the 24-hour MA period and no MA period

Parameter24-Hour MA PeriodNo MA Period
Population Mean EstimateRSE%CV%Population Mean EstimateRSE%CV%
ka (h−1)3.6541.61033.5554.956.0
k12 (h−1)1.7119.432.51.5471.562.6
k21 (h−1)2.0214.423.12.4064.929.7
V1 (liters)31.238.817.727.756.820.2
V2 (liters)24.447.224.618.452.837.2
TLag (h−1)0.1554.51070.1476.281.2
CLCAPX (l/h)2.7315.022.72.6317.319.6
CLPX (l/h)3.8111.213.43.7014.210.9
CLCAO (l/h)4.8640.157.13.7449.068.1
IC(1) (mg)1.7282.32293.40144187
IC(2) (mg)1.20Fixed1.21Fixed
IC(3) (mg)4.0622.848.26.9377.2103
IC(4) (mg)1.37Fixed1.18Fixed
SD1intercept0.05Fixed0.05Fixed
SD1slope0.0238.80.0713.7
SD2intercept0.05Fixed0.05Fixed
SD2slope0.0432.20.0429.9
  • CV%, coefficient of variation percentage (represents the true biologic variability between the participants); IC(i), Initial condition in the ith compartment; RSE%, relative standard error as a percentage (represents the precision of the parameter estimate); SD1intercept, variance model parameter describing additive residual error of caffeine; SD1slope, variance model parameter describing the proportional residual error of caffeine; SD2intercept, variance model parameter describing additive residual error of paraxanthine; SD2slope, variance model parameter describing proportional residual error of paraxanthine.